Like many other industries, medical technology has shifted the production of components or entire products to locations with low labor costs. The weaknesses of this strategy become apparent in times of a pandemic, as sometimes drastic supply bottlenecks can occur. The solution:
Distributed production is used to bring manufacturing structures back to locations where it makes sense, and procurement takes place within robust supply chains.
It is important for the future that this strategy is pursued not only in a concrete emergency, but also on a long-term basis.What does that look like in concrete terms? Read our showcase on the production of swabs for corona test kits in Australia, Canada and Spain.